May 16th, 2023 3-5PM ET

Tuesday on The Robert Scott Bell Show:

Farewell Questions for Rochelle Walensky Given what we now know about the complete failure of covid vaccines to provide sterilizing immunity, stop infection, or stop spread as well as the fact that such issues were not even tested for in the drug trials that approved them, certain questions would seem to demand asking: Just what was this “Data from the CDC today” that suggested that “Vaccinated people do not carry the virus?” Was there, in fact, any data at all? Or was this a completely fabricated claim used to underpin the mass rollout of a product that failed so spectacularly right out of the gates and: Where the sorts of safety and inefficacy signals that would have pulled any other vaccine in history off the market were ignored. Where the data collection was rigged to make known adverse events difficult to find, report, and aggregate in the V-safe system by removing them from searchable database fields and placing them in free text response. And where the mandated safety assessments were not being performed until long after problems were evident, allowing the CDC to miss the most blatant safety signal in history. There seem to be an awfully large body of claims made by CDC that appear to have lacked foundation in fact or data. Both Dr Walensky and her predecessor Robert Redfield would seem to have a great deal to answer for here.

Judge Orders FDA to Accelerate Release of COVID-19 Vaccine Trial Data to Just 2 Years A federal judge in Texas ordered the Food and Drug Administration (FDA) to make public data it relied on to license COVID-19 vaccines at an accelerated rate, requiring all documents to be made public by mid-2025 rather than, as the FDA wanted, over the course of about 23.5 years. In a May 9 decision hailed as a win for transparency by the lawyer representing the plaintiffs (the parents of a child injured by a COVID-19 vaccine) in a lawsuit (pdf) against the FDA, the agency was ordered to produce the data on Moderna’s vaccine for adults and Pfizer’s for children about 10 times faster than the agency wanted. “Democracy dies behind closed doors,” is how U.S. District Judge Mark Pittman opened his order (pdf), which requires the FDA to produce the data on Moderna’s and Pfizer’s COVID-19 vaccines at an average rate of at least 180,000 pages per month. The FDA had argued it would be “impractical” to release the estimated 4.8 million pages at more than between 1,000 and 16,000 pages per month, which would have taken at least 23.5 years. Aaron Siri of Siri & Glimstad, who represents the plaintiffs in the legal action against the FDA, called the decision “another blow for transparency and accountability” that builds on an earlier court order targeting Pfizer’s COVID-19 vaccine data for those aged 16 and older. The January 2022 order (pdf), also issued by Pittman, forced the FDA to produce all its data on Pfizer’s COVID-19 vaccine for those aged 16 and older at a rate of 55,000 pages per month, or much faster than the 75 years the agency had sought.

Special Guest Paul Barattiero, ND

Paul is the Founder of Echo Technologies. Paul has been a pioneer and leader in the hydrogen water industry for 15 years. He has labored to bring to market cutting-edge, scientific-based, natural-healing technologies to facilitate detoxification, gut recovery, and reduction of oxidative stress. You can find him featured in numerous shows and documentaries, and he has co-authored several books. Paul lives with his family in the mountains of Utah.

Dr. Wendell Whitman was a tireless advocate for health freedom and a pioneer in the field of natural health. In 1991, recognizing the inadequacy of formal health education outside of the traditional medical field, he founded Trinity School of Natural Health.

Trinity School of Natural Health was founded for the purpose of presenting alternative natural health education to everyone. Today, the Trinity repertoire of programs and courses has evolved into a powerful, educational process that enables students to improve their own health, enhance the good health of their families, friends and communities, and their own professional practices.

Our philosophy is that we are intrinsically holistic and should therefore continually pursue true health through the development of the physical, emotional and spiritual aspects of the whole person. Our vision is to become the global leader in natural health education by creating a community of individuals who are committed to sharing their knowledge of the power and purpose of holistic health. As we strive to create an exceptional student experience, we will treat each person who chooses Trinity with respect and dignity. Every decision made, every single day, will be focused solely on what is best for our students.

Hour 2

Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health Patients are now enrolling in an early-stage clinical trial to test a universal flu vaccine based on messenger RNA technology, the National Institutes of Health announced Monday. Scientists hope the vaccine will protect against a wide variety of flu strains and provide long-term immunity so people do not have to receive a shot every year. Messenger RNA, or mRNA, is the technology behind Moderna’s and Pfizer’s widely used Covid vaccines. NIH played a crucial role in developing the mRNA platform used by Moderna.  “A universal flu vaccine could serve as an important line of defense against the spread of a future flu pandemic,” Dr. Hugh Auchincloss, acting director of National Institute of Allergy and Infectious Diseases, said in a statement Monday. The universal flu vaccine trial will enroll up to 50 healthy people ages 18 through 49 to test whether the experimental shot is safe and produces an immune response, according to NIH. The study will also include participants who receive a quadrivalent flu vaccine, which protects against four strains of the virus, to compare the experimental universal shot to those currently on the market. The universal shot was developed by researchers at the National Institute of Allergy and Infectious Diseases. The clinical trial is enrolling volunteers at Duke University in Durham, North Carolina.

Special Guest Dr. Rashid Buttar

Save 10% on tickets with promo code “RSB”

Dr. Rashid A. Buttar received his undergraduate degree from Washington University in St. Louis with a double major in Biology and Theology and then attended medical school at the University of Osteopathic Medicine and Health Sciences, College of Osteopathic Medicine and Surgery in Des Moines, Iowa. He trained in General Surgery and Emergency Medicine and served as Brigade Surgeon for 2nd Infantry Division, Republic of South Korea, and later as Chief of theDepartment of Emergency Medicine at Moncrief Army Community Hospital at Ft. Jackson in Columbia, South Carolina while serving in the US Army. During his military career, Dr. Buttar had the privilege of serving with and being attached to the 2nd Infantry Division, the 101st Air Assault Division and the 5th Special Forces Group. Dr. Buttar is board certified and a Diplomate in Clinical Metal Toxicology and Preventive Medicine, is board eligible in Emergency Medicine and has achieved fellowship status in three separate medical organizations (Fellow of the American College for Advancement in Medicine, Fellow of the American Academy of Preventive Medicine, and Fellow of the American Association of Integrative Medicine). Dr. Buttar practices in Charlotte, NC where he is the medical director of Advanced Concepts in Medicine, The Center for Advanced Medicine and Clinical Research. The Center specializes in the treatment and needs of patients refractory to conventional treatments and who have failed the standard approach to their disease process. With a special emphasis on the interrelationship between environmental toxicity and the insidious disease processes and the “up regulation” of the immune system, the Center has attracted patients from 34 different countries all over the world suffering from cancer, heart disease, stroke, autism and many other conditions too numerous to list.

New menopause drug for hot flashes gets FDA approval U.S. health regulators on Friday approved a new type of drug for women dealing with uncomfortable hot flashes caused by menopause. The Food and Drug Administration approved the once-a-day pill from Astellas Pharma to treat moderate-to-severe symptoms, which can include sweating, flushing and chills. Astellas’ drug, Veozah, uses a new approach, targeting brain connections that help control body temperature. The FDA said the medication will provide “an additional safe and effective treatment option for women,” in a statement. More than 80% of women experience hot flashes during menopause, the FDA noted, as the body gradually produces lower levels of reproductive hormones between the ages of 45 and 55. The most common treatment consists of hormonal pills aimed at boosting levels of estrogen and progestin. But the treatment isn’t appropriate for some women, including those with a history of stroke, blood clots, heart attack and other health conditions. Large studies have found that the hormones can increase the chances of those problems reoccurring, although the risks vary based on a number of individual factors. The new pill is not a hormone. It carries an FDA warning about potential liver damage. Women will need to be screened for liver damage or infection before getting a prescription, then get a blood test every three months for nine months to monitor for safety problems, according to the FDA label. Astellas said the drug will cost $550 for a one-month supply.

Remember Friends, The Power to Heal is Yours!